Firefly Neuroscience (AIFF)
NASDAQ:AIFF
AIFF Stock Chart & Stats
$1.05
-$0.10(-4.05%)
At close: 4:00 PM EST
$1.05
-$0.10(-4.05%)
Day’s Range― - ―
52-Week Range$0.62 - $4.51
Previous CloseN/A
Volume11.65K
Average Volume (3M)316.76K
Market Cap
$22.19M
Enterprise Value$19.44M
Total Cash (Recent Filing)$2.75M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.54
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.64
Shares Outstanding14,793,075
10 Day Avg. Volume358,037
30 Day Avg. Volume316,761
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)1.51
Price to Sales (P/S)10.11
P/FCF Ratio-1.39
Enterprise Value/Market Cap0.88
Enterprise Value/Revenue17.03
Enterprise Value/Gross Profit30.14
Enterprise Value/Ebitda-0.99
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance Sheet HealthFirefly's 2025 balance sheet shows material improvement with positive equity and no reported debt, providing a stronger capital base and lower financial risk. A debt-free structure improves resilience, access to capital on better terms and reduces bankruptcy risk over the next several quarters.
Revenue Rebound & Gross MarginRevenue recovery paired with a ~56% gross margin indicates the core software/analytics model can deliver high incremental margins. If revenue growth sustains, this margin profile supports scalable economics and the potential to leverage fixed R&D and G&A toward durable profitability over a multi-quarter horizon.
Strategic Neurotech PositioningFirefly's focus on AI-driven EEG analytics addresses a structural industry need for objective brain biomarkers. Software-based analytics in clinical/research workflows are scalable, support recurring engagements, and position the company to benefit from growing demand for quantified neurologic endpoints over coming years.
Bears Say
High Cash BurnMaterial negative operating and free cash flows in 2025 reflect sustained cash consumption well beyond current revenue, creating a structural dependency on external capital. Continued high burn compresses runway, forces repeated financings or deep cuts, and constrains long-term investment in product and sales scaling.
Losses Dwarf RevenuesA near-$20M loss against a sub-$2M revenue base highlights a cost structure far ahead of current sales. This structural mismatch means the company must achieve sustained, sizable revenue growth or materially reduce costs to reach sustainable margins, raising execution risk in the medium term.
Dependence On Equity FinancingThe ATM program and recent private placement demonstrate ongoing reliance on equity markets for working capital. Persistent equity raises create dilution risk, can limit strategic flexibility, and signal dependence on external funding to sustain operations unless cash generation meaningfully improves.
Firefly Neuroscience News
AIFF FAQ
What was Firefly Neuroscience’s price range in the past 12 months?
Firefly Neuroscience lowest stock price was $0.62 and its highest was $4.51 in the past 12 months.
What is Firefly Neuroscience’s market cap?
Firefly Neuroscience’s market cap is $22.19M.
When is Firefly Neuroscience’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Firefly Neuroscience’s earnings last quarter?
Firefly Neuroscience released its earnings results on May 14, 2024. The company reported -$0.335 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.335.
Is Firefly Neuroscience overvalued?
According to Wall Street analysts Firefly Neuroscience’s price is currently Overvalued.
Does Firefly Neuroscience pay dividends?
Firefly Neuroscience does not currently pay dividends.
What is Firefly Neuroscience’s EPS estimate?
Firefly Neuroscience’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Firefly Neuroscience have?
Firefly Neuroscience has 14,793,075 shares outstanding.
What happened to Firefly Neuroscience’s price movement after its last earnings report?
Firefly Neuroscience reported an EPS of -$0.335 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.455%.
Which hedge fund is a major shareholder of Firefly Neuroscience?
Currently, no hedge funds are holding shares in AIFF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Firefly Neuroscience
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
Technical Analysis
Ownership Overview
12.98% Insiders
3.74% Mutual Funds
0.08% Other Institutional Investors
79.91% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---